Literature DB >> 36178453

Guideline on allergen immunotherapy in IgE-mediated allergic diseases: S2K Guideline of the German Society of Allergology and Clinical Immunology (DGAKI), Society of Pediatric Allergology and Environmental Medicine (GPA), Medical Association of German Allergologists (AeDA), Austrian Society of Allergology and Immunology (ÖGAI), Swiss Society for Allergology and Immunology (SSAI), German Dermatological Society (DDG), German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), German Society of Pediatrics and Adolescent Medicine (DGKJ), Society of Pediatric Pulmonology (GPP), German Respiratory Society (DGP), German Professional Association of Otolaryngologists (BVHNO), German Association of Paediatric and Adolescent Care Specialists (BVKJ), Federal Association of Pneumologists, Sleep and Respiratory Physicians (BdP), Professional Association of German Dermatologists (BVDD).

Oliver Pfaar1, Tobias Ankermann2, Matthias Augustin3, Petra Bubel4, Sebastian Böing5, Randolf Brehler6, Peter A Eng7, Peter J Fischer8, Michael Gerstlauer9, Eckard Hamelmann10, Thilo Jakob11, Jörg Kleine-Tebbe12, Matthias Volkmar Kopp13, Susanne Lau14, Norbert Mülleneisen15, Christoph Müller16, Katja Nemat17,18, Wolfgang Pfützner19, Joachim Saloga20, Klaus Strömer21, Peter Schmid-Grendelmeier22, Antje Schuster23, Gunter Johannes Sturm24, Christian Taube25, Zsolt Szépfalusi26, Christian Vogelberg27, Martin Wagenmann28, Wolfgang Wehrmann29, Thomas Werfel30, Stefan Wöhrl31, Margitta Worm32, Bettina Wedi30, Susanne Kaul33, Vera Mahler33, Anja Schwalfenberg34.   

Abstract

Not available. © Dustri-Verlag Dr. K. Feistle.

Entities:  

Keywords:  allergen; allergen extract; allergen immunotherapy; allergic asthma; allergic disease; allergic rhinitis; allergic rhinoconjunctivitis; guideline; hyposensitization

Year:  2022        PMID: 36178453      PMCID: PMC9513845          DOI: 10.5414/ALX02331E

Source DB:  PubMed          Journal:  Allergol Select        ISSN: 2512-8957


  347 in total

1.  Subcutaneous Immunotherapy With High-Dose Cat and Dog Extracts: A Real-life Study.

Authors:  S A Uriarte; J Sastre
Journal:  J Investig Allergol Clin Immunol       Date:  2019-05-27       Impact factor: 4.333

2.  Double-blind, placebo-controlled study of immunotherapy with Parietaria judaica: clinical efficacy and tolerance.

Authors:  M Ferrer; E Burches; A Peláez; A Muñoz; D Hernández; A Basomba; E Enrique; R Alonso; A Cisteró-Bahima; S Martín; P Rico; B Gandarias
Journal:  J Investig Allergol Clin Immunol       Date:  2005       Impact factor: 4.333

3.  Tree-pollen allergy is efficiently treated by short-term immunotherapy (STI) with seven preseasonal injections of molecular standardized allergens.

Authors:  B R Balda; H Wolf; C Baumgarten; L Klimek; G Rasp; G Kunkel; S Müller; W Mann; B Hauswald; W Heppt; B Przybilla; U Amon; R Bischoff; G Becher; S Hummel; P J Frosch; T Rustemeyer; L Jäger; R Brehler; T Luger; J Schnitker
Journal:  Allergy       Date:  1998-08       Impact factor: 13.146

4.  The efficacy and safety of two commercial house dust mite extracts for allergic rhinitis: a head-to-head study.

Authors:  Jie Li; Yuying Wu; Yongshi Yang; Nan Huang; Wenjing Li; Shuchen Zhang; Qing Jiang; Lin Yang; Rongfei Zhu
Journal:  Int Forum Allergy Rhinol       Date:  2019-07-19       Impact factor: 3.858

5.  Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy.

Authors:  Albrecht Bufe; Peter Eberle; Eivy Franke-Beckmann; Jürgen Funck; Martin Kimmig; Ludger Klimek; Roland Knecht; Volker Stephan; Bente Tholstrup; Christian Weisshaar; Friedrich Kaiser
Journal:  J Allergy Clin Immunol       Date:  2009-01       Impact factor: 10.793

6.  Efficacy and tolerability of a house dust mite allergoid in allergic bronchial asthma: a randomized dose-ranging trial.

Authors:  Marek Jutel; Michael Rudert; Fabian Kreimendahl; Piotr Kuna
Journal:  Immunotherapy       Date:  2018-08-09       Impact factor: 4.196

7.  Side effects during subcutaneous immunotherapy in children with allergic diseases.

Authors:  Max A Tophof; Anne Hermanns; Thomas Adelt; Peter Eberle; Christine Gronke; Frank Friedrichs; Roland Knecht; Ernst Mönter; Helmut Schöpfer; Nicolaus Schwerk; Jörg Steinbach; Hans-Ulrich Umpfenbach; Christian Weißhaar; Brigitte Wilmsmeyer; Albrecht Bufe
Journal:  Pediatr Allergy Immunol       Date:  2018-01-17       Impact factor: 6.377

8.  Allergen specificity of IgG(4)-expressing B cells in patients with grass pollen allergy undergoing immunotherapy.

Authors:  Louisa K James; Holly Bowen; Rosaleen A Calvert; Tihomir S Dodev; Mohamed H Shamji; Andrew J Beavil; James M McDonnell; Stephen R Durham; Hannah J Gould
Journal:  J Allergy Clin Immunol       Date:  2012-05-13       Impact factor: 10.793

9.  Efficacy of Sublingual Immunotherapy for House Dust Mite-Induced Allergic Rhinitis: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Bohai Feng; Haijie Xiang; Haiyong Jin; Jinjian Gao; Saiyu Huang; Yunbin Shi; Ruru Chen; Bobei Chen
Journal:  Allergy Asthma Immunol Res       Date:  2017-05       Impact factor: 5.764

10.  A 12-week DBPC dose-finding study with sublingual monomeric allergoid tablets in house dust mite-allergic patients.

Authors:  C Hüser; P Dieterich; J Singh; K Shah-Hosseini; S Allekotte; W Lehmacher; E Compalati; R Mösges
Journal:  Allergy       Date:  2016-05-10       Impact factor: 13.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.